Treace Medical Concepts, Inc.
US ˙ NasdaqGS ˙ US89455T1097

SecurityTMCI / Treace Medical Concepts, Inc.
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership113,702 shares
Latest Disclosed Value $ 152,361
Engineers Gate Manager LP reports 156.07% increase in ownership of TMCI / Treace Medical Concepts, Inc.

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 113,702 shares of Treace Medical Concepts, Inc. (US:TMCI) valued at $152,361 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 44,403 shares of Treace Medical Concepts, Inc.. This represents a change in shares of 156.07% during the quarter. The current value of the position is $386,587 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TREACE MED CONCEPTS COM 89455T109 113,702 69,299 156.07 152 40.74 0.0019
2026-02-17 2025-12-31 13F TREACE MED CONCEPTS COM 89455T109 44,403 44,403 109 0.0013
2025-08-14 2025-06-30 13F TREACE MED CONCEPTS COM 89455T109 0 -22,717 -100.00 0 -100.00
2025-05-15 2025-03-31 13F TREACE MED CONCEPTS COM 89455T109 22,717 -10,827 -32.28 191 -23.69 0.0032
2025-02-14 2024-12-31 13F TREACE MED CONCEPTS COM 89455T109 33,544 9,545 39.77 250 79.14 0.0043
2024-11-14 2024-09-30 13F TREACE MED CONCEPTS COM 89455T109 23,999 23,999 139 0.0027
2023-11-14 2023-09-30 13F TREACE MED CONCEPTS COM 89455T109 0 -53,298 -100.00 0 -100.00
2023-08-14 2023-06-30 13F TREACE MED CONCEPTS COM 89455T109 53,298 -29,409 -35.56 1,363 -34.57 0.0515
2023-05-15 2023-03-31 13F TREACE MED CONCEPTS COM 89455T109 82,707 57,564 228.95 2,083 260.38 0.0870
2023-02-14 2022-12-31 13F TREACE MED CONCEPTS COM 89455T109 25,143 25,143 578 0.0347
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.